Trump considers approving Covid-19 vaccine ahead of U.S. elections

Trump considers approving Covid-19 vaccine ahead of U.S. elections

The FDA could authorize by emergency rules, despite fears of authorities waiving for security reasons

The Trump administration is considering circumventing normal US regulatory standards to speed up approval of a UK experimental coronavirus vaccine for use in the U.S. before the presidential election, according to three people informed about the plan.

An option being evaluated to speed up the availability of a vaccine would involve the Food and Drug Agency (FDA) granting “emergency use authorization” (USA) in October for a vaccine being developed in partnership between the pharmaceutical company AstraZeneca and the University of Oxford, based on the results of a relatively small study carried out in the United Kingdom, if it is successful, the sources said.

Read more at Folha de S.Paulo.

Este artigo está disponível em: Português

Related posts
PoliticsWorld

Trump finally promises transition as calls mount to remove him

PoliticsWorld

Cabinet members discussing Trump's removal: US media

PoliticsWorld

Audio shows Trump's attempt to alter Georgia election result

PoliticsWorld

Trump appeals decision that prevents US TikTok ban

Assine nossa Newsletter